Clinical Trial Update: Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety [Phase 4]

View source ↗

Summary

Phase 4 trial of aripiprazole for schizophrenia with co-morbid social anxiety completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Social Anxiety Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED